Skip to main content
. 2014 Dec 17;9:93–102. doi: 10.2147/DDDT.S75464

Figure 2.

Figure 2

Kaplan–Meier estimator (5-year follow-up).

Notes: Absence of cutaneous malignancy recurrence in patients with/without mTOR inhibitor therapy after diagnosis of initial tumor.

Abbreviation: mTOR, mammalian target of rapamycin.